Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues

Cardiovascular Research

Volumn 48, Issue 1, 2000, Pages 101-110

  Imanishi, Toshio ^a   Murry, Charles E ^b   Reinecke, Hans ^b   Hano, Takuzo ^a   Nishio, Ichiro ^a   Liles, W Conrad ^b   Hofsta, Leonard ^c   Kim, Koanhoi ^b   O'Brien, Kevin D ^b   Schwartz, Stephen M ^b   Han, David K M ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Cardiomyopathy; Heart failure; Histo(patho)logy; Myocytes

Indexed keywords

CASPASE 8; CASPASE 8 LIKE INHIBITOR PROTEIN; DNA; FAS ANTIGEN; FAS LIGAND; INHIBITOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; HEART FAILURE; HEART GRAFT; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADULT; ANIMAL; ANIMALS, NEWBORN; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL TRANSPLANTATION; COCULTURE; DNA FRAGMENTATION; DOGS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; MODELS, ANIMAL; MYOCARDIUM; RATS; RATS, INBRED F344; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033781314     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00154-1     Document Type: Article

References (44)

1. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Englar R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
2. Bardales R.H., Hailey L.S., Xie S.S., Schaefer R.F., Hsu S.M. In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol. 149:1996;821-829.
3. Saraste A., Pulkki K., Kallojoki M., Henricksen K., Parvinen M., Voipio-Pulkki L.-M. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
4. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. New Engl J Med. 335:1996;1182-1189.
5. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. New Engl J Med. 336:1997;1131-1141.
6. Bing O.H.L. Hypothesis: Apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiology. 26:1994;943-948.
7. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
8. Abbas A.K. Die and let die: Eliminating dangerous lymphocytes. Cell. 84:1996;655-657.
9. Sata M., Walsh K. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J Clin Invest. 102:1998;1682-1689.
10. Geng Y.J., Henderson L.E., Levesque E.B., Muszynski M., Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 17:1997;2200-2208.
11. Boise L.H., Thompson C.B. Bcl-XL can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci USA. 94:1997;3759-3764.
12. Thome M., Schneider P., Hofman K., et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:1997;517-527.
13. Hu S., Vincenz C., Buller M., Dixit V.M. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis. J Biol Chem. 272:1997;9621-9624.
14. Irmer M., Thome M., Hahne M., et al. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195.
15. Shu H.B., Halpin D.R., Goeddel D.V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity. 6:1997;751-763.
16. Srinvasula S.M., Ahmad M., Ottile S., et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem. 272:1997;18542-18545.
17. Goltsev Y.V., Kovalenko A.V., Arnold E., Varolomeev E.E., Brodianskii V.M., Wallach D. CASH, a novel caspase homologue with death effector domains. J Biol Chem. 272:1997;19641-19644.
18. Rasper D.M., Vaillancourt J.P., Hadano S., et al. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD95 (Fas, APO-1) receptor complex. Cell Death Different. 5:1998;271-288.
19. Han D.K.M., Chaudhary P.M., Wright M.E., et al. MRIT, a novel-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc Natl Acad Sci USA. 94:1997;11333-11338.
20. Nishigaki K., Minatoguchi S., Seishima M., et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, and inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol. 29:1997;1214-1220.
21. Toyozaki T., Hiroe M., Tanaka M., Nagata S., Ohwada H., Marumo F. Levels of soluble Fas ligand in myocarditis. Am J Cardiol. 82:1998;246-248.
22. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med. 323:1990;236-241.
23. McMurray J., Abdullah I., Dargie H.J., Shapiro D. Increased concentrations of tumor necrosis factor in cachectic patients with severe chronic heart failure. Br Heart J. 66:1991;356-358.
24. Kiener P.A., Davis P.M., Rankin B.M., et al. Human monocytic cells contain high levels of intracellular Fas ligand - rapid release following cellular activation. J Immunol. 159:1997;1594-1598.
25. Kagi D.F., Vignaux B., Ledermann B., et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxity. Science. 265:1994;528-530.
26. Reinecke H., Zhang M., Bartosek T., Murry C.E. Survival, integration, and differentiation of cardiocyte grafts. A study in normal and injured rat hearts. Circulation. 100:1999;193-202.
27. Murry C.E., Kay M.A., Bartosek T., Hauschka S.D., Schwartz S.M. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest. 98:1996;2209-2217.
28. Imanishi T, McBride J, Ho Q, O'Brien KD, Schwartz SM, Han DKM. Expression of cellular caspase inhibitor FLIP in human coronary arteries and in a rat vascular injury model. Am J Pathol, in press.
29. Han D.K.M., Haudenschild C.C., Hong M.K., Tinkle B.T., Leon M.B., Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 147:1995;267-277.
30. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest. 82:1988;1134-1143.
31. Tewari M., Dixit V.M. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem. 270:1995;3255-3260.
32. Watanebe E., Smith D.M., Delcarpio J.B., et al. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant. 7:1998;239-246.
33. Leor J., Patterson M., Quinones M.J., Kedes L.H., Kloner R.A. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation. 94:(Suppl II):1996;332-336.
34. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemic/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
35. Scaffidi C., Schmitz I., Krammer P.H., Peter M.E. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem. 274:1999;1541-1548.
36. Algeciras-Schimnich A., Griffith T.S., Lynch D.H., Paya C.V. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol. 162:1999;5205-5211.
37. Kayagaki N., Kawasaki A., Ebata T., et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 182:1995;1777-1783.
38. Mariani S.M., Matiba B., Baumler C., Krammer P.H. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol. 25:1995;2303-2307.
39. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding. Nature Med. 4:1996;31-46.
40. Schneider P., Holler N., Bodmer J.L., Hahne M., Fontana A., Tschopp J. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 187:1998;1205-1213.
41. Matute-Bello G., Liles W.C., Steinberg K.P., et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol. 163:1999;2217-2225.
42. Pollman M.J., Hall J.L., Muhring J., Knaapen M.W.M., de Meyer G.R.Y. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Med. 4:1998;222-228.
43. Kockx M.M., Muhring J., Knaapen M.W.M., de Meyer G.R.Y. RNA synthesis and splicing interferes with DNA in situ end labeling techniques and to direct apoptosis. Am J Pathol. 152:1998;885-888.
44. Schwartz S.M., Bennett M.R. Death by any other name. Am J Pathol. 147:1995;229-234.